Fundraising Fox
Imcheck
acquired by Clementia11 known investors
Find your way into Imcheck
Sign up to see every warm intro you have to Imcheck
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Imcheck team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ImCheck Therapeutics develops next-generation immunotherapeutic antibodies targeting the butyrophilin (BTN) and BTN-like (BTNL) superfamily of checkpoint molecules for immune system modulation. Its programs address cancer, infectious disease, and autoimmune disease.
Founders & leadership
Investors · 11
How we know: Agent Capital's portfolio page · press coverage · the VCSheet dataset · Not right? Tell us
How we know: Andera Partners's portfolio page · Not right? Tell us
How we know: Kurma Partners's portfolio page · a partner's Signal profile · press coverage · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Pfizer Venture Investments's portfolio page · Not right? Tell us
How we know: Pureos Bioventures's portfolio page · a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: press coverage · Not right? Tell us
How we know: press coverage · Not right? Tell us
How we know: press coverage · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
How we know: press coverage · Not right? Tell us
How we know: press coverage · Not right? Tell us
In the news
Frequently asked questions
- What does Imcheck do?
- ImCheck Therapeutics develops next-generation immunotherapeutic antibodies targeting the butyrophilin (BTN) and BTN-like (BTNL) superfamily of checkpoint molecules for immune system modulation. Its programs address cancer, infectious disease, and autoimmune disease.
- Who founded Imcheck?
- Imcheck was founded by Daniel Olive.
- Who are Imcheck's investors?
- Imcheck's investors include Agent Capital, Andera Partners, Kurma Partners, Pfizer Venture Investments, Pureos Bioventures, Alexandria, Bpifrance, EQT Life Sciences and 3 more.
- Who acquired Imcheck?
- Imcheck was acquired by Clementia.